文献速递衰弱、肌少症与跌倒

低肌力老年人骨骼肌中肌源性与应激因子差异表达的初步证据

Preliminary Evidence of Differential Expression of Myogenic and Stress Factors in Skeletal Muscle of Older Adults With Low Muscle Strength.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2022-01-01

本研究比较了肌力保留与低肌力的老年人骨骼肌蛋白表达谱,涉及分解代谢、氧化、应激及肌源性通路。低肌力组线粒体标志物 COX-IV 较低,应激因子 CHOP 和 p-ERK1/2 升高约1.5倍,肌源性因子 Pax7、MyoD、desmin 升高约2倍,而分解代谢信号无差异。提示应激因子升高可能反映组织稳态恶化,肌源性标志物上调可能是对肌肉质与量丢失的代偿尝试。

要点

  • 低肌力老年人骨骼肌中 COX-IV 较低而 CHOP、p-ERK1/2 升高约1.5倍
  • 低肌力组肌源性因子 Pax7、MyoD、desmin 表达升高约2倍
  • 分解代谢信号 FOXO1/3a、MuRF1、MAFbx、LC3b、Atg5、p62 两组无差异

核心结论

  • 低肌力老年人骨骼肌应激因子 CHOP 和 p-ERK1/2 升高,肌源性因子 Pax7、MyoD、desmin 也升高,分解代谢信号无差异。

研究设计与样本

  • 比较肌力保留组(8女5男,71.5±2.6岁)与低肌力组(6女5男,78.0±5.0岁)老年人骨骼肌蛋白表达谱的初步研究。

主要发现

  • 低肌力组线粒体标志物 COX-IV 较低,但 PGC1α 和柠檬酸合酶无差异。
  • 低肌力组应激因子 CHOP 和 p-ERK1/2 升高约1.5倍。
  • 肌力保留组炎症标志物 p-p65NF-κB 升高约7倍。
  • 低肌力组肌源性因子 Pax7、MyoD、desmin 升高约2倍。
  • 分解代谢信号 FOXO1/3a、MuRF1、MAFbx、LC3b、Atg5、p62 两组无差异表达。

关键数值与推荐

  • 低肌力按 EWGSOP2 标准定义:椅子站立试验时间超过15秒和/或握力女性低于16 kg、男性低于27 kg。

临床怎么用

  • 对低肌力老年人可关注应激因子与肌源性因子表达变化所提示的肌肉稳态失衡。
  • 检测线粒体标志物 COX-IV 可能有助于识别低肌力老年人的线粒体功能变化。
  • 肌源性因子升高可能反映代偿尝试,需结合临床评估肌肉质与量变化。

局限性

  • 研究为初步证据,样本量小,组间年龄存在差异。
  • 原文未报告混杂因素控制及因果推断信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The age-related loss of muscle strength and mass, or sarcopenia, is a growing concern in the aging population. Yet, it is not fully understood which molecular mechanisms underlie sarcopenia. Therefore, the present study compared the protein expression profile, such as catabolic, oxidative, stress-related, and myogenic pathways, between older adults with preserved (8 ♀ and 5 ♂; 71.5 ± 2.6 years) and low muscle strength (6 ♀ and 5 ♂; 78.0 ± 5.0 years). Low muscle strength was defined as chair stand test time more than 15 seconds and/or handgrip strength less than 16 kg (women) or less than 27 kg (men) according to the EWGSOP2 criteria. Catabolic signaling (ie, FOXO1/3a, MuRF1, MAFbx, LC3b, Atg5, p62) was not differentially expressed between both groups, whereas the mitochondrial marker COX-IV, but not PGC1α and citrate synthase, was lower in the low muscle strength group. Stress factors CHOP and p-ERK1/2 were higher (~1.5-fold) in older adults with low muscle strength. Surprisingly, the inflammatory marker p-p65NF-κB was ~7-fold higher in older adults with preserved muscle strength. Finally, expression of myogenic factors (ie, Pax7, MyoD, desmin; ~2-fold) was higher in adults with low muscle strength. To conclude, whereas the increased stress factors might reflect the age-related deterioration of tissue homeostasis, for example, due to misfolded proteins (CHOP), upregulation of myogenic markers in the low strength group might be an attempt to compensate for the gradual loss in muscle quantity and quality. These data might provide valuable insights into the processes that underlie sarcopenia.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Dalle S, Dupont J, Dedeyne L, et al. Preliminary Evidence of Differential Expression of Myogenic and Stress Factors in Skeletal Muscle of Older Adults With Low Muscle Strength. J Gerontol A Biol Sci Med Sci. 2022. PMID: 34984449. doi:10.1093/gerona/glac002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。